Genetic analysis of blood vessel formation: Role of endothelial versus smooth muscle cells

Trends in Cardiovascular Medicine

Volumn 7, Issue 8, 1997, Pages 271-281

  Carmeliet, Peter ^a   Collen, Désiré ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR; THROMBIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANGIOGENESIS; BLOOD CLOTTING; BLOOD VESSEL; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GENETIC ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0030695920     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00093-5     Document Type: Review

References (77)

1. Alpers CE, Seifert RA, Hudkins KL, Johnson RJ, Bowen-Pope DF: 1992. Developmental patterns of PDGFB-chain, PDGF receptor and alpha-actin expression in human glomerulogenesis. Kidney Int 42:390-399.
2. Altieri DC: 1995. Xa receptor EPR-1. FASEB J 9:860-865.
3. Antonelli-Orlidge A, Saunders KB, Smith SR, d'Amore PA: 1989. An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA 86:4544-4548.
4. Battegay EJ: 1995. Angiogenesis: mechanistic insights, neovascular disease and therapeutic prospects. J Mol Med 73:333-346.
5. Battegay EJ, Rupp J, Iruela-Arispe L, Sage EH, Pech M: 1994. PDGF-BB modulates endothelial cell proliferation and angiogenesis in vitro via PDGFβ receptors. J Cell Biol 125: 917-928.
6. Bi L, Lawler AM, Antonarakis SE, High KA, Gearhart JD, Kazazaian HH Jr: 1995. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet 10:119-121.
7. Bugge TH, Xiao Q, Kombrinck K, et al.: 1996. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci USA 93:6258-6263.
8. Carmeliet P, Ferreira V, Breier G, et al.: 1996a. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439.
9. Carmeliet P, Mackman N, Moons L, et al.: 1996b. Role of the cellular receptor tissue factor in embryonic vessel development. Nature 383:73-75.
10. Carmeliet P, Moons L, Dewerchin M, et al.: 1997. Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor and the plasminogen system. Ann NY Acad Sci 811:191-206.
11. Conolly A, Ishihara H, Kahn ML, Farese RV, Coughlin SR: 1996. Role of the thrombin receptor in development and evidence for a second receptor. Nature 381:516-519.
12. Coughlin SR: 1994. Molecular mechanisms of thrombin signaling. Semin Hematol 31:270-277.
13. Cui J, O'Shea KS, Purkayastha A, Saunders TL, Ginsburg D: 1996. Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature 384:66-68.
14. D'Amore PA, Smith SR: 1993. Growth factor effects on cells of the vascular wall: a survey. Growth Factors 8:61-75.
15. Darrow AL, Fung-Leung WP, Ye RD, et al.: 1996. Biological consequences of thrombin receptor deficiency in mice. Thromb Haemost 76:860-866.
16. Davie E.: 1995. Biochemical and molecular aspects of the coagulation cascade. Thromb Haemost 74:1-6.
17. Davis S, Aldrich TH, Jones PF, et al.: 1996. Isolation of angiopoietin-1, a ligand for the angiogenic TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161-1769.
18. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: 1992. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991.
19. Dickson MC, Martin JS, Cousins JS, Kulkarni AB, Karisson S, Akhurst RJ: 1995. Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice. Development 121:1845-1854.
20. Dumont DJ, Gradwohl G, Fong G-H, et al: 1994. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8:1897-1909.
21. Dvorak HF, Brown LF, Detmar M, Dvorak AM: 1995. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039.
22. Edgington TS, Mackman N, Brand K, Ruf W: 1991. The structural biology of expression and function of tissue factor. Thromb Haemost 66:67-79.
23. Ferrara N, Carver-Moore K, Chen H, et al.: 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442.
24. Ferrara N, Davis-Smyth T: 1997. The biology of vascular endothelial growth factor. Endocrine Reviews 18:4-25.
25. Flamme I, Risau W: 1992. Induction of vasculogenesis and hematopoiesis in vitro. Development 116:435-439.
26. Folkman J, d'Amore PA: 1996. Blood vessel formation: what is its molecular basis? Cell 87: 1153-1155.
27. Fong GH, Rossant J, Breitman ML: 1995. Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70.
28. Frank R, Adelmann-Grill BC, Herrmann K, Haustein UF, Petri JB, Heckmann M: 1996. Transforming growth factor-beta controls cell matrix interaction of microvascular dermal endothelial cells by downregulation of integrin expression. J Invest Dermatol 106: 36-41.
29. Gasic GP, Arenas CP, Gasic TB, Gasic GJ: 1992. Coagulation factors X, Xa and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci USA 89: 2317-2320.
30. Grotendorst GR, Chang HEF, Seppä HK, Kleinman HK, Martin GR: 1982. Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells. J Cell Physiol 113: 261-266.
31. Hanahan D: 1997. Signaling vascular morphogenesis and maintenance. Science 277:48-50.
32. Harker LA, Hanson SR, Runge MS: 1995. Thrombin hypothesis of thrombus generation and vascular lesion formation. Am J Cardiol 75:12B-17B.
33. Heldin CH, Westermark B: 1989. Platelet-derived growth factor: three isoforms and two receptor types. Trends Genet 5:108-111.
34. Holmgren L, Glaser A, Pfeifer-Ohlsson S, Ohlsson R: 1991. Angiogenesis during human extraembryonic development involves the spatiotemporal control of the PDGF ligand and receptor gene expression. Development 113: 749-754.
35. Iruela-Arispe ML, Sage EH: 1993. Endothelial cells exhibiting angiogenesis in vitro proliferate in response to TGF-beta 1. J Cell Biochem 52:414-130.
36. Jeltsch M, Kappainen AA, Joukov V, et al.: 1997. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423-1425.
37. Joukov V, Pajusola K, Kaipanenen A, et al.: 1996. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290-298.
38. Kingsley DM: 1994. The TGFβ superfamily: new members, new receptors and new genetic tests of functions in different organisms. Genes Dev 8:133-146.
39. Klagsbrun M, Dluz S: 1993. Smooth muscle cell and endothelial cell growth factors. Trends Cardiovasc Med 3:213-217.
40. Lee J, Gray A, Yuan J, Luoh SM, Avraham H, Wood WI: 1996. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci USA 93:1988-1992.
41. Levéen P, Pekny M, Gebre-Medhin S, Swolin B, Larsson E, Betsholtz C: 1994. Mice deficient for PDGF B show renal, cardiovascular and hematological abnormalities. Genes Dev 8:1875-1887.
42. Lindahl P, Johansson BR, Levéen P, Betsholtz C: 1997. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277:242-245.
43. Lindner V, Reidy MA. Platelet-derived growth factor ligand and receptor expression by large vessel endothelium in vivo. Am J Pathol 146:1488-1497.
44. Luther T, Flössel C, Mackman N, et al.: 1996. Tissue factor expression during human and mouse development. Am J Pathol 149:101-113.
45. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG: 1991. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88:9267-9271.
46. Maisonpierre PC, Suri C, Jones PF, et al.: 1997 Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60
47. Maltepe E, Schmidt JV, Baunoch D et al.: 1997. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386:403-407.
48. McAllister KA, Grogg KM, Johnson DW, et al.: 1994. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type-1. Nat Genet 8:345-351.
49. Metcalfe JC, Grainger DJ: 1995. TGF-β: implications for human vascular disease. J Hum Hypertens 9:679-683.
50. Mustonen T, Alitalo K: 1995. Endothelial receptor kinases involved in angiogenesis. J Cell Biol 129:895-898.
51. Nelhs V, Drenckhan D: 1993. The versatility of microvascular pericytes: from mesenchymal cell to smooth muscle cell? Histochemistry 99:1-12
52. Nunes I, Munger JS, Harpel JG, et al.: 1996. Structure and activation of the large latent transforming growth factor-β complex. Int J Obes Relat Metab Disord 20:S4-S8.
53. Okamoto N, Tobe T, Hackett SF et al.: 1997. Transgenic mice with increased expression of vascular endothelial growth factor in the retina. Am J Pathol 151:281-291.
54. Oloffson B, Pjausola K, Kaipanen A, et al.: 1996. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 93:2576-2581.
55. Orlandinin M, Marconcini M, Ferruzzi R, Olivierro S: 1996. Identification of a c-fos-induced gene that is related to platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci USA 93:11,675-11,680.
56. Patan S, Haenni B, Burri PH: 1996. Implementation of intussusceptive microvascular growth in the chicken chorio-allantoic membrane (CAM): 1. Pillar formation by folding of the capillary wall. Microvasc Res 51:80-98.
57. Pepper MS, Vassalli JD, Orci L, Montesano R: 1993. Biphasic effects of transforming growth factor-beta 1 on in vitro angiogenesis. Exp Cell Res 204:356-363.
58. Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J: 1995. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J 14:5884-5891.
59. Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT: 1993. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 90: 7533-7537.
60. Risau W: 1997. Mechanisms of angiogenesis. Nature 386:671-674.
61. Rohovsky SA, Hirshi KK, d'Amore P: 1996. Surg Forum 47:390-391.
62. Rosen E, Chan JY, Esohe I, et al.: 1997. Factor VII deficient mice develop normally but suffer fatal perinatal bleeding. Nature (in press).
63. Ross R, Raines EW, Bowen-Pope DF: 1986. The biology of platelet-derived growth factor. Cell 46:155-169.
64. 2 signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor. J Biol Chem 270:4650-4660.
65. Sato TN, Qin Y, Kozak CA, Audus K: 1993, tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci USA 90:9355-9358.
66. Sato T, Tozawa Y, Deutsch U, et al.: 1995. Distinct roles of the receptor tyrosine kinase TIE-1 and TIE-2 in blood vessel formation. Nature 376:70-74.
67. Sawano A, Takahashi T, Yamaguchi S, Aonumura M, Shibuya M: 1996. Fit-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ 7:213-221.
68. Shalaby F, Rossant J, Yamaguchi TP, Bretiman ML, Schuh AC: 1995. Failure of blood island formation, vasculogenesis and haematopoiesis in flk-1 deficient mice. Nature 376:62-66.
69. Shalaby F, Ho J, Stanford WL, et al.: 1997. A requirement for Flk-1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89:981-990.
70. Soifer SJ, Peters KG, O'Keefe J, Coughlin SR: 1994. Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development. Am J Pathol 144: 60-69.
71. Soriano P: 1994. Abnormal kidney development and hematological disorders in PDGF β-receptor mutant mice. Genes Dev 8:1888-1896.
72. Suh TT, Holmbäck K, Jensen NJ, et al.: 1995. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen deficient mice. Genes Dev 9:2020-2033.
73. Suri C, Jones PF, Patan S, et al.: 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogensis. Cell 87:1171-1180.
74. Terman BI, Doughervermazen: 1996. Biological properties of VEGF/VPF receptors. Cancer Metastasis Rev 15:159-163.
75. Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze GJ Jr: 1996. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 88:1583-1587.
76. Vikkula M, Boon LM, Carraway KL, et al.: 1996. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87:1181-1190.
77. Zhang Y, Deng Y Luther T, et al.: 1994. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 1320-1327.